Stéphanie Michaud is the President and CEO of BioCanRx, a not-for-profit that seeks to accelerate the delivery of innovative immunotherapies from the bench to the bedside. In this position, Stephanie is responsible for running all facets of the organization. She brings more than 20 years of public, government and private sector experience in research and S&T innovation policy. She strives to create partnerships between government, not-for-profits, academia and industry to maximize the impact of research funded by the BioCanRx network on the lives of those affected by cancer. This includes the creation of new opportunities to include the patient voice as equal partner in the BioCanRx research program
Prior to joining BioCanRx, Stéphanie was Deputy Director of the flagship Government of Canada Network Centres of Excellence (NCE) program. She is a strong contributor to S&T policy, most notably in intellectual property.
Dr. Michaud earned a PhD in Organic Chemistry from McGill University. She is involved with a number of not-for-profit organizations including as a Director of the Board of Research Canada.
All Sessions by Dr. Stéphanie MichaudPrinter Friendly See Full Agenda
Agenda: Day 1 Oct 5, 2020
Agenda: Day 2 Oct 6, 2020